Скачать или смотреть Join SIBO Resolution FB Group!

FB Group   / 786681227764995  
Small Intestinal Bacterial Overgrowth (SIBO): Understanding the Condition and the Functional Medicine Approach
Small intestinal bacterial overgrowth (SIBO) is a disorder characterized by excessive bacterial proliferation in the small intestine, where bacterial counts normally remain low compared to the colon. This overgrowth interferes with digestion and nutrient absorption, producing symptoms such as abdominal bloating, pain, diarrhea, constipation, fatigue, and malabsorption-related deficiencies. Prevalence estimates suggest SIBO affects up to 60% of individuals with irritable bowel syndrome (IBS) and is linked to conditions including hypothyroidism, diabetes, and post-surgical adhesions.
Conventional medical management typically relies on antibiotics, such as rifaximin, to reduce bacterial load, often combined with dietary modifications like low-FODMAP protocols. While effective for symptom relief in many cases, recurrence rates exceed 40% within months, as standard treatments frequently fail to address underlying drivers.
Functional medicine offers a systems-oriented, patient-centered framework that seeks to identify and correct root causes rather than merely suppressing symptoms. Practitioners view SIBO as a manifestation of broader gastrointestinal dysfunction, emphasizing personalized interventions based on comprehensive assessment.
Key root causes explored in functional medicine include impaired gut motility (e.g., from vagal nerve dysfunction or medications), insufficient digestive secretions (low stomach acid from proton pump inhibitor use), structural abnormalities (adhesions, diverticula), immune dysregulation, and microbiome imbalances often precipitated by prior antibiotic exposure or stress.
Diagnosis extends beyond standard breath testing (lactulose or glucose) to include advanced stool analysis for dysbiosis, organic acid testing for microbial metabolites, and evaluations of nutrient status and food sensitivities. This multifaceted testing enables precise targeting of contributing factors.
Treatment follows structured protocols, commonly the 5R framework: Remove pathogenic overgrowth using herbal antimicrobials (e.g., berberine, oregano oil) or pharmaceuticals; Replace digestive factors (enzymes, betaine HCl); Reinoculate with targeted probiotics; Repair intestinal lining (glutamine, zinc carnosine); and Rebalance through lifestyle adjustments (stress reduction, sleep optimization, meal spacing).
Dietary strategies are tailored: low-FODMAP or specific carbohydrate diets reduce fermentable substrates during eradication phases, transitioning to broader anti-inflammatory patterns for maintenance. Prokinetic agents, natural or prescription, enhance migrating motor complex activity to prevent relapse.
Evidence supports herbal protocols achieving comparable eradication rates to rifaximin, with advantages in recurrence prevention when combined with motility and mucosal support. Functional medicine's integrative approach addresses comorbidities, yielding sustained improvements in symptoms and quality of life.
By prioritizing root-cause resolution and personalization, functional medicine provides a comprehensive strategy for managing SIBO, reducing recurrence, and restoring optimal gut function.